The influence of storage time and temperature on G-6PD enzyme activity for the enzymatic colorimetric measurement

Autores/as

DOI:

https://doi.org/10.11606/issn.2176-7262.rmrp.2025.223027

Palabras clave:

G-6PD deficiency, Filter paper, Colorimetric enzymatic method, Pre-analytical conditions, Glucose-6-phosphate dehydrogenase

Resumen

Background: To ensure accurate results when measuring glucose-6-phosphate dehydrogenase (G-6PD) enzyme activity, it is essential to take care of pre-analytical aspects related to time and storage conditions. This study sought to identify the ideal conditions for measuring G-6PD activity on filter paper using a colorimetric enzymatic method. Methods: The biological material was collected from 17 individuals deficient in G-6PD enzyme activity and 19 with normal enzyme activity and stored in three conditions: room temperature (25.5ºC), refrigerated (5ºC), and at -20ºC. Furthermore, the G-6PD enzyme activity was evaluated daily for 15 days by the colorimetric enzymatic method. Results and Conclusion: The results revealed that 81% of the sample's enzymatic activity was explained by the linear regression model, considering temperature, the time between collection and analysis, and the individual's state of disability. At the end of the storage period, samples kept at room temperature showed significant instability, losing around 61% of enzymatic activity. This emphasizes the negative influence of temperature on G-6PD enzyme activity and highlights the importance of analyzing biological material within 48 hours. On the other hand, the samples stored under cryopreservation (-20ºC) showed greater stability, preserving more than 60% of the residual activity. This highlights the need for appropriate treatment for samples collected in locations far from the analysis laboratory. Refrigerated samples can be stored for up to seven days without affecting the classification of the individual. Finally, samples stored at -20°C proved to be the most stable option throughout the entire storage period, with no error in the individual's classification.

Descargas

Los datos de descarga aún no están disponibles.

Biografía del autor/a

  • Indiara Correia Pereira, Universidade Federal de Mato Grosso do Sul

    Doutora

  • Clovis Paniz, Universidade Federal de Santa Maria, Departamento de análises Clínicas e Toxicológicas, Santa Maria, (RS), Brasil

    Professor Doutor

  • Elvira Maria Guerra Shinohara, Universidade de São Paulo, Faculdade de Ciências Farmacêuticas, São Paulo, (SP), Brasil

    Professora Doutora

  • Marcela Zuza de Almeida, Instituto de Pesquisas, Ensino e Diagnósticos da APAE, Campo Grande, (MS), Brasil

    Técnica de laboratório

  • Josaine Sousa Palmiere Oliveira, Instituto de Pesquisas, Ensino e Diagnósticos da APAE, Campo Grande, (MS), Brasil

    Mestre

  • Renata Trentin Perdomo, Universidade Federal de Mato Grosso do Sul, Laboratório de Biologia Molecular e Cultura Célula, Campo Grande, (MS), Brasil

    Professora Doutora

Referencias

1 Beutler, E. G-6PD deficiency. Blood. 1994; 84: 3613-3636. DOI: 10.1182/blood.V84.11.3613.bloodjournal84113613

2 Frank, J. E. Diagnosis and management of G-6PD deficiency. American family physician. 2005; 72:1277-1282.

3 Harcke, S. J., Rizzolo, D., Harcke, H. T. G-6PD deficiency: An update. Journal of the American Academy of Physician Assistants. 2019; 32: 21-26. DOI:10.1097/01.JAA.0000586304.65429.a7

4 Nair, A. K., Al Khusaiby, S. M. Kernicterus and G-6PD deficiency - a case series from Oman. Journal of tropical pediatrics. 2003; 49: 74-77. DOI: 10.1093/tropej/49.2.74

5 Watchko, J. F. Refractory causes of kernicterus in developed countries: can we eradicate G-6PD deficiency triggered and low-bilirubin kernicterus?. Current pediatric reviews. 2017; 13: 159-168. DOI: 10.2174/1573396313666170718144025

6 Mallouh, A., Imseeh, G., Abu-Osba, Y. K., Hamdan, J. A. Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice. Annals of tropical paediatrics, 1992; 12: 391-395. DOI: 10.1080/02724936.1992.11747604

7 Mezzacappa, M., et al. Clinical and genetic risk factors for moderate hyperbilirubinemia in Brazilian newborn infants. Journal of Perinatology. 2010; 30: 819-826. DOI: 10.1038/jp.2010.48

8 Baird, J. K. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clinical microbiology reviews. 2013; 26: 36-57. DOI: 10.1128/CMR.00074-12

9 Castro, S. M., Weber, R., Dadalt, V., Santos, V. F., Reclos, G. J., Pass, K. A., Giugliani, R. Evaluation of glucose-6-phosphate dehydrogenase stability in blood samples under different collection and storage conditions. Clinical chemistry. 2005; 51: 1080-1081. DOI: 10.1373/clinchem.2005.048520

10 Flores, S. R., Hall, E. M., De Jesús, V. R. Glucose-6-phosphate dehydrogenase enzyme stability in filter paper dried blood spots. Clinical biochemistry. 2017; 50: 878-881. DOI: 10.1016/j.clinbiochem.2017.05.003

11 Brazil. Ministry of Health. Secretariat of Health Care. Department of Specialized and Thematic Care. Neonatal biological screening: technical manual. Brasília: Ministry of Health; 2016.

12 Cappellini, M. D., Fiorelli., G. Glucose-6-phosphate dehydrogenase deficiency. The lancet. 2008; 371: 64-74. DOI: 10.1016/S0140-6736(08)60073-2

13 Manning, D., Todd, P., Maxwell, M., Platt, J. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2007; 92: 342-346. DOI: 10.1136/adc.2006.105361

14 WHO, Working Group Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ. 1989; 67: 601-611.

15 Guthrie, R., Susi, A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963; 32: 338-343. DOI: 10.1542/peds.32.3.338

16 Sahai, I., Marsden, D. Newborn screening. Critical Reviews in Clinical Laboratory Sciences. 2009; 46: 55-82. DOI: 10.1080/10408360802485305

17 Chamchoy, K., A. et al. The integrity and stability of specimens under different storage conditions for glucose-6-phosphate dehydrogenase deficiency screening using WST-8. Acta Tropica. 2021; 217: 105864. DOI: 10.1016/j.actatropica.2021.105864

18 Boonyuen, U., Chamchoy, K., Swangsri, T., Junkree, T., Day, N. P., White, N. J., Imwong, M. A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G-6PD) deficiency. International Journal of Biological Macromolecules. 2017; 104: 145-156. DOI: 10.1016/j.ijbiomac.2017.06.002

19 Praoparotai, A., Junkree, T., Imwong, M., Boonyuen, U. Functional and structural analysis of double and triple mutants reveals the contribution of protein instability to clinical manifestations of G-6PD variants. International journal of biological macromolecules. 2020; 158: 884-893. DOI: 10.1016/j.ijbiomac.2020.05.026

Descargas

Publicado

2026-03-31

Número

Sección

Artigo Original

Cómo citar

1.
Pereira IC, Paniz C, Shinohara EMG, Almeida MZ de, Oliveira JSP, Perdomo RT. The influence of storage time and temperature on G-6PD enzyme activity for the enzymatic colorimetric measurement. Medicina (Ribeirão Preto) [Internet]. 31 de marzo de 2026 [citado 2 de abril de 2026];58(4):e-223027. Disponible en: https://revistas.usp.br/rmrp/article/view/223027